Predict your next investment

HEALTHCARE | Drug Development
yizhongpharma.com

See what CB Insights has to offer

Founded Year

2009

Stage

IPO | IPO

Date of IPO

9/9/2021

About Yizhong Pharmaceutical

Yizhong Pharmaceutical (688091.SH) is committed to the development and industrialization of new and improved anti-tumor drugs.

Yizhong Pharmaceutical Headquarter Location

79 Renqi Road, Fengxian District

Shanghai, Shanghai,

China

+86-021-37190005

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Yizhong Pharmaceutical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Yizhong Pharmaceutical is included in 1 Expert Collection, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.